-
公开(公告)号:US11903935B2
公开(公告)日:2024-02-20
申请号:US17508321
申请日:2021-10-22
发明人: Jeffrey Milbrandt , Kow Essuman , Yo Sasaki , Aaron Diantonio , Xianrong Mao , Rajesh Devraj , Raul Eduardo Krauss , Robert Owen Hughes
IPC分类号: A61K31/4439 , A61K47/55 , A61K47/52 , A61P25/28 , A61K33/243 , A61K31/047 , A61K31/145 , A61K31/198 , A61K31/41 , A61K31/437 , A61K31/4375 , A61K31/444 , A61K31/4535 , A61K31/566 , A61K31/7048 , A61K31/7084 , A61K33/245 , A61K33/28 , A61K33/30
CPC分类号: A61K31/4439 , A61K31/047 , A61K31/145 , A61K31/198 , A61K31/41 , A61K31/437 , A61K31/4375 , A61K31/444 , A61K31/4535 , A61K31/566 , A61K31/7048 , A61K31/7084 , A61K33/243 , A61K33/245 , A61K33/28 , A61K33/30 , A61K47/52 , A61K47/55 , A61P25/28
摘要: The present disclosure provides compounds useful as inhibitors of SARM1 NADase activity, compositions thereof, and methods of using the same. The present disclosure provides compounds useful for treating a neurodegenerative or neurological disease or disorder, compositions thereof, and methods of using the same.